Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Chapter 2: Kill the bacteria...and also their messengers?

Munford R, Lu M, Varley A.

Adv Immunol. 2009;103:29-48. doi: 10.1016/S0065-2776(09)03002-8. Review.

2.

Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection.

Lu M, Varley AW, Ohta S, Hardwick J, Munford RS.

Cell Host Microbe. 2008 Sep 11;4(3):293-302. doi: 10.1016/j.chom.2008.06.009.

3.

Mechanisms of disposal of bacterial lipopolysaccharides by animal hosts.

Elsbach P.

Microbes Infect. 2000 Aug;2(10):1171-80. Review.

PMID:
11008107
4.

Resistance to polymyxins: Mechanisms, frequency and treatment options.

Falagas ME, Rafailidis PI, Matthaiou DK.

Drug Resist Updat. 2010 Aug-Oct;13(4-5):132-8. doi: 10.1016/j.drup.2010.05.002. Epub 2010 Jun 17. Review.

PMID:
20843473
5.
6.

[Gram-negative virulent bacterial lipopolysaccharide: role in infection and immunity].

Vorobév AA, Borisova EV, Borisov VA.

Vestn Ross Akad Med Nauk. 1997;(3):10-3. Review. Russian.

PMID:
9181847
7.

Lipopolysaccharide neutralizing peptide-porphyrin conjugates for effective photoinactivation and intracellular imaging of gram-negative bacteria strains.

Liu F, Soh Yan Ni A, Lim Y, Mohanram H, Bhattacharjya S, Xing B.

Bioconjug Chem. 2012 Aug 15;23(8):1639-47. doi: 10.1021/bc300203d. Epub 2012 Jul 17.

PMID:
22769015
8.

Persistently active microbial molecules prolong innate immune tolerance in vivo.

Lu M, Varley AW, Munford RS.

PLoS Pathog. 2013 May;9(5):e1003339. doi: 10.1371/journal.ppat.1003339. Epub 2013 May 9.

9.

Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria.

Lu M, Zhang M, Takashima A, Weiss J, Apicella MA, Li XH, Yuan D, Munford RS.

Nat Immunol. 2005 Oct;6(10):989-94. Epub 2005 Sep 11.

PMID:
16155573
10.

Clinical implications of antibiotic-induced endotoxin release in septic shock.

Lepper PM, Held TK, Schneider EM, Bölke E, Gerlach H, Trautmann M.

Intensive Care Med. 2002 Jul;28(7):824-33. Epub 2002 May 30. Review.

PMID:
12122518
11.

Molecular genetics and role in infection of environmentally regulated lipopolysaccharide expression.

Preston A, Maskell DJ.

Int J Med Microbiol. 2002 Jun;292(1):7-15. Review.

PMID:
12139431
12.

Microbe-associated molecular patterns in innate immunity: Extraction and chemical analysis of gram-negative bacterial lipopolysaccharides.

De Castro C, Parrilli M, Holst O, Molinaro A.

Methods Enzymol. 2010;480:89-115. doi: 10.1016/S0076-6879(10)80005-9. Review.

PMID:
20816206
13.

Disarming the invader.

Young GM.

Chem Biol. 2003 Mar;10(3):204-5.

14.

Transport of lipopolysaccharide to the Gram-negative bacterial cell surface.

Putker F, Bos MP, Tommassen J.

FEMS Microbiol Rev. 2015 Nov;39(6):985-1002. doi: 10.1093/femsre/fuv026. Epub 2015 Jun 1. Review.

PMID:
26038291
15.

Silver enhances antibiotic activity against gram-negative bacteria.

Morones-Ramirez JR, Winkler JA, Spina CS, Collins JJ.

Sci Transl Med. 2013 Jun 19;5(190):190ra81. doi: 10.1126/scitranslmed.3006276.

16.

Overproduction of acyloxyacyl hydrolase by macrophages and dendritic cells prevents prolonged reactions to bacterial lipopolysaccharide in vivo.

Ojogun N, Kuang TY, Shao B, Greaves DR, Munford RS, Varley AW.

J Infect Dis. 2009 Dec 1;200(11):1685-93. doi: 10.1086/646616.

17.

Endotoxins: lipopolysaccharides of gram-negative bacteria.

Wang X, Quinn PJ.

Subcell Biochem. 2010;53:3-25. doi: 10.1007/978-90-481-9078-2_1.

PMID:
20593260
19.

Biosynthesis, transport, and modification of lipid A.

Trent MS.

Biochem Cell Biol. 2004 Feb;82(1):71-86. Review.

PMID:
15052329
20.

The Kdo biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and development.

Cipolla L, Polissi A, Airoldi C, Galliani P, Sperandeo P, Nicotra F.

Curr Drug Discov Technol. 2009 Mar;6(1):19-33. Review.

PMID:
19275539
Items per page

Supplemental Content

Write to the Help Desk